Company Filing History:
Years Active: 2018
Title: Klára Dáñová: Innovator in Immunology
Introduction
Klára Dáñová is a prominent inventor based in Prague, Czech Republic. He has made significant contributions to the field of immunology, particularly in the development of methods for producing tolerogenic dendritic cells. His work aims to advance treatments for autoimmune diseases and improve graft acceptance in transplant procedures.
Latest Patents
Klára Dáñová holds a patent titled "Tolerogenic dendritic cells, methods of producing the same, and uses thereof." This patent describes methods for the preparation of stable semi-mature tolerogenic dendritic cells and compositions that include these cells. The stable semi-mature tolerogenic dendritic cells can be utilized to establish immune tolerance, which is crucial in treating autoimmune diseases, graft rejection, and graft-versus-host disease. He has 1 patent to his name.
Career Highlights
Dáñová is associated with Sotio a.s., a company focused on innovative therapies in oncology and immunology. His work at Sotio a.s. has positioned him as a key player in the development of advanced therapeutic solutions.
Collaborations
Throughout his career, Klára has collaborated with notable colleagues, including Lenka Palová Jelínková and Radek Špísek. These collaborations have further enriched his research and contributed to the advancement of immunological therapies.
Conclusion
Klára Dáñová's innovative work in the field of immunology, particularly through his patent on tolerogenic dendritic cells, showcases his commitment to improving treatment options for patients with autoimmune diseases and those undergoing transplants. His contributions are paving the way for future advancements in medical science.